Showing results (1-10 of 11) with videos related to
Sort By:
Pageof 2
Cell Reports|March 15, 2018
A PP6-ASK3 Module Coordinates the Bidirectional Cell Volume Regulation under Osmotic StressKengo Watanabe, Tsuyoshi Umeda, Kuniyoshi Niwa, et al.Scientific Reports|January 7, 2016
Osmotic stress induces the phosphorylation of WNK4 Ser575 via the p38MAPK-MK pathwayJunichi Maruyama, Yumie Kobayashi, Tsuyoshi Umeda, et al.Journal of Neuroendovascular Therapy|July 28, 2023
A Patient with a Cavernous Sinus Dural Arteriovenous Fistula in Whom an Approach through the Jugular Venous Arch Involving Facial Vein Return Was AdoptedTakayuki Nagase, Koji Tokunaga, Kyoichi Watanabe, et al.The Journal of Biological Chemistry|January 11, 2007
Apoptosis signal-regulating kinase (ASK) 2 functions as a mitogen-activated protein kinase kinase kinase in a heteromeric complex with ASK1Kohsuke Takeda, Rieko Shimozono, Takuya Noguchi, et al.Genes to Cells : Devoted to Molecular & Cellular Mechanisms|August 1, 2007
Chk2 kinase is required for methylglyoxal-induced G2/M cell-cycle checkpoint arrest: implication of cell-cycle checkpoint regulation in diabetic oxidative stress signalingShuichi Kani, Emiko Nakayama, Akinori Yoda, et al.Nature Communications|December 20, 2012
ASK3 responds to osmotic stress and regulates blood pressure by suppressing WNK1-SPAK/OSR1 signaling in the kidneyIsao Naguro, Tsuyoshi Umeda, Yumie Kobayashi, et al.Journal of Neuro-Oncology|January 22, 2025
Identification of factors related to functional prognoses in craniopharyngiomasTsuyoshi Umeda, Yoshihiro Otani, Kentaro Fujii, et al.Brain Tumor Pathology|October 21, 2024
Tectal glioma: clinical, radiological, and pathological features, and the importance of molecular analysisRyoji Imoto, Yoshihiro Otani, Kentaro Fujii, et al.Journal of Neurosurgery|December 27, 2024
Comparative analysis of intraoperative MRI and early postoperative MRI findings in glioma surgery patientsYoshihiro Otani, Fumiyo Higaki, Kentaro Fujii, et al.Iscience|October 7, 2025
Dual molecular therapy targeting tumor cell heterogeneity improves therapeutic efficacy in glioblastomaShuichiro Hirano, Atsuhito Uneda, Yoshihiro Otani, et al.Pageof 2